首页> 外文期刊>Indian journal of pharmaceutical sciences. >Study on impact of clinical pharmacist's interventions in the optimal use of oral anticoagulants in stroke patients
【24h】

Study on impact of clinical pharmacist's interventions in the optimal use of oral anticoagulants in stroke patients

机译:临床药师干预对中风患者口服抗凝剂最佳使用的影响研究

获取原文
获取原文并翻译 | 示例
       

摘要

Anticoagulants are very useful medications but can also lead to haemorrhagic as well as thromboembolic complications when not used correctly or without proper medical attention. Anticoagulant's complex pharmacology and pharmacokinetics contribute to its narrow margin of safety. Pharmacist's unique knowledge of pharmacology, pharmacokinetics and interactions makes them well-suited to assist patients in maintaining safe and effective anticoagulation. Successful anticoagulation therapy implies fewer incidences of therapeutic failures and bleeding complications. The anticoagulation management service staffed by clinical pharmacists is a service established to monitor and manage oral and parenteral anticoagulants. In this research work, 40 patients each were included in the intervention and the control groups. In the intervention group, patient's knowledge score on anticoagulation increased from an average of 5.6±3.2 to 13.8±0.94 (P=0.000) after clinical pharmacist's counselling, whereas in the control group there was no significant improvement in patient's baseline knowledge over the knowledge score at the end of the study (8.0±1.59 vs. 8.3±2.6) (P=0.218). In the intervention group, 73.45% of the international normalised ratio test results were within the therapeutic range, 8.45% supratherapeutic and 18.5% subtherapeutic during the 6 months data collection period. The corresponding data for the control group were 53.2 (P=0.000), 18.4 (P=0.000) and 28.4% (P=0.002), respectively. Forty four adverse drug reactions (ADRs) related to anticoagulants were identified in the intervention group as compared to 56 in the control group. These results revealed that the clinical pharmacist's involvement in the anticoagulation management improved the therapeutic outcome of patients and demonstrate the benefits of clinical pharmacist guided anticoagulation clinics in India.
机译:抗凝剂是非常有用的药物,但如果使用不当或没有适当的医疗护理,也会导致出血以及血栓栓塞并发症。抗凝剂复杂的药理学和药代动力学特性使其安全性范围狭窄。药剂师在药理学,药代动力学和相互作用方面的独特知识使其非常适合帮助患者维持安全有效的抗凝治疗。成功的抗凝治疗意味着更少的治疗失败和出血并发症发生。由临床药剂师配备的抗凝管理服务是一项旨在监视和管理口服和肠胃外抗凝剂的服务。在这项研究工作中,干预组和对照组各包括40名患者。在干预组中,在临床药剂师的指导下,患者的抗凝知识得分从平均5.6±3.2提高到13.8±0.94(P = 0.000),而在对照组中,患者的基础知识知识得分无明显改善研究结束时(8.0±1.59 vs. 8.3±2.6)(P = 0.218)。在干预组中,在6个月的数据收集期间,国际标准化比率测试结果的73.45%在治疗范围内,8.4%的治疗范围内和18.5%的亚治疗范围内。对照组的相应数据分别为53.2(P = 0.000),18.4(P = 0.000)和28.4%(P = 0.002)。在干预组中确定了与抗凝剂相关的44种药物不良反应(ADR),而在对照组中则为56种。这些结果表明,临床药剂师参与抗凝治疗改善了患者的治疗效果,并证明了印度由临床药剂师指导的抗凝诊所的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号